These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 8339266

  • 21. Leukemia inhibitory factor in long-term adherent layer cultures: increased levels of bioactive protein in leukemia and modulation by IL-4, IL-1 beta, and TNF-alpha.
    Wetzler M, Estrov Z, Talpaz M, Kim KJ, Alphonso M, Srinivasan R, Kurzrock R.
    Cancer Res; 1994 Apr 01; 54(7):1837-42. PubMed ID: 8137298
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Inhibition of the ABL kinase activity blocks the proliferation of BCR/ABL+ leukemic cells and induces apoptosis.
    Gambacorti-Passerini C, le Coutre P, Mologni L, Fanelli M, Bertazzoli C, Marchesi E, Di Nicola M, Biondi A, Corneo GM, Belotti D, Pogliani E, Lydon NB.
    Blood Cells Mol Dis; 1997 Dec 01; 23(3):380-94. PubMed ID: 9446752
    [Abstract] [Full Text] [Related]

  • 25. Alternative 5' end of the bcr-abl transcript in chronic myelogenous leukemia.
    Romero P, Beran M, Shtalrid M, Andersson B, Talpaz M, Blick M.
    Oncogene; 1989 Jan 01; 4(1):93-8. PubMed ID: 2915904
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Experimental systems in CML biology].
    Maru Y.
    Nihon Rinsho; 2001 Dec 01; 59(12):2322-8. PubMed ID: 11766333
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Establishment and characterization of a novel cell line, TK-6, derived from T cell blast crisis of chronic myelogenous leukemia, with the secretion of parathyroid hormone-related protein.
    Watanabe T, Kataoka T, Mizuta S, Kobayashi M, Uchida T, Imai K, Wada H, Kinoshita T, Murate T, Mizutani S.
    Leukemia; 1995 Nov 01; 9(11):1926-34. PubMed ID: 7475285
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The severe combined immunodeficient (SCID) mouse as a model for human myeloid leukemias.
    Cesano A, Hoxie JA, Lange B, Nowell PC, Bishop J, Santoli D.
    Oncogene; 1992 May 01; 7(5):827-36. PubMed ID: 1570153
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Establishment and characterization of a new Ph1-positive chronic myeloid leukemia cell line MC3 with trilineage phenotype and an altered p53 gene.
    Okabe M, Kunieda Y, Nakane S, Kurosawa M, Itaya T, Vogler WR, Shoji M, Miyazaki T.
    Leuk Lymphoma; 1995 Feb 01; 16(5-6):493-503. PubMed ID: 7787756
    [Abstract] [Full Text] [Related]

  • 38. A novel CD10-positive erythroid cell line, RM10, established from a patient with chronic myelogenous leukemia.
    Hirata J, Sato H, Takahira H, Shiokawa S, Endo T, Nishimura J, Katsuno M, Masuda S, Sasaki R, Fukumaki Y.
    Leukemia; 1990 May 01; 4(5):365-72. PubMed ID: 2167410
    [Abstract] [Full Text] [Related]

  • 39. Potential therapeutic applications of antisense oligodeoxynucleotides in the treatment of chronic myelogenous leukemia.
    Gewirtz AM.
    Leuk Lymphoma; 1993 May 01; 11 Suppl 1():131-7. PubMed ID: 7504543
    [Abstract] [Full Text] [Related]

  • 40. Natural killer cell-mediated inhibition of growth of myeloid and lymphoid clonogenic leukemias.
    Savary CA, Lotzová E.
    Exp Hematol; 1989 Feb 01; 17(2):183-7. PubMed ID: 2912742
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.